INNOVENT BIO (HKEX: 01801) has announced the granting of share-based awards to certain employees.
According to a company filing, on June 15, 2026, the firm issued 5,000 share options to one grantee and 105,200 restricted shares to 22 grantees under the terms of its 2024 Share Scheme, subject to acceptance by the recipients.
All recipients are non-connected employees of the group who are not part of senior management.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments